title: Response to letter regarding article 'Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis'.
authors.affiliation: Department of Clinical Immunology, Fremantle Hospital, Fremantle, WA, Australia.
authors.forename: Anna M
authors.initials: AM
authors.lastname: Brusch
authors.forename: Russell C
authors.initials: RC
authors.lastname: Clarke
authors.forename: Peter R
authors.initials: PR
authors.lastname: Platt
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Phillips
mesh_terms: D000485:Allergens / Q000276:immunology*; D064751:Ammonium Compounds / Q000276:immunology*; D000707:Anaphylaxis / Q000276:immunology*; D003061:Codeine / Q000031:analogs & derivatives*; D004342:Drug Hypersensitivity / Q000276:immunology*; D006801:Humans; D009025:Morpholines / Q000276:immunology*; D009466:Neuromuscular Blocking Agents / Q000276:immunology*
chemical_list: D000485:Allergens; D064751:Ammonium Compounds; D009025:Morpholines; D009466:Neuromuscular Blocking Agents; D003061:Codeine